MIAMI, FL--(Marketwire - June 25, 2008) - OncoMune, a leader in targeted cancer therapeutics, today announced the appointment of Dr. Christopher J. Dougherty, Ph.D., Research Professor at Florida Atlantic University (FAU), as Chief Scientific Officer.
